Abatacept (Orencia) is a novel infusion for the treatment of rheumatoid arthritis

被引：0
|
作者：
Nolan, Mark
机构：
来源：
EJHP PRACTICE | 2008年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [31] Abatacept for rheumatoid arthritis
    Rojahn, Ruth
    INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE, 2011, 9 (04): : 456 - 457
  • [32] Abatacept for rheumatoid arthritis
    Maxwell, Lara
    Singh, Jasvinder A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [33] First Year Canadian Experience with Subcutaneous Abatacept in Routine Practice for the Treatment of Patients with Rheumatoid Arthritis: Data from the Orencia Response Program (ORP) Network
    Haraoui, Boulos
    Coupal, Louis
    Day, Radmila
    Budry, Lionel
    Chalabi, Youb
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [34] First Year Canadian Experience with Subcutaneous Abatacept in Routine Practice for the Treatment of Patients with Rheumatoid Arthritis: Data from the Orencia Response Program (ORP) Network
    Haraoui, Boulos
    Coupal, Louis
    Day, Radmila
    Budry, Lionel
    Chalabi, Youb
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) : 1221 - 1222
  • [35] The impact of abatacept treatment on the vasculature in patients with rheumatoid arthritis
    Sandoo, A.
    Kitas, G. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (04) : 589 - 589
  • [36] Alternatives in the treatment of rheumatoid arthritis: reasons for using abatacept
    Castaneda, S.
    Martinez Calatrava, M. J.
    Herrero-Beaumont, G.
    REVISTA CLINICA ESPANOLA, 2012, 212 (05): : 244 - 254
  • [37] Abatacept in the long-term treatment of rheumatoid arthritis
    Jani, Meghna
    Hyrich, Kimme L.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (03) : 231 - 234
  • [38] Abatacept for Treatment of Rheumatoid Arthritis: Special Focus on the Elderly
    Soubrier, Martin
    Lahaye, Clement
    Tatar, Zuzana
    DRUGS & AGING, 2018, 35 (05) : 379 - 387
  • [39] Patient and physician perception of the infusion process of the biologic agents abatacept, infliximab, and rituximab for the treatment of rheumatoid arthritis
    Yazici, Y.
    McMorris, B. J.
    Darkow, T.
    Rosenblatt, L. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (06) : 907 - 913
  • [40] Abatacept: the evidence for its place in the treatment of rheumatoid arthritis
    Koeller, Marcus D.
    CORE EVIDENCE, 2007, 2 (03) : 163 - 172
12345